Schwenkglenks, Matthias and Brazier, John E. and Szucs, Thomas D. and Fox, Keith A. A.. (2011) Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. Value in health, Vol. 14, H. 1. pp. 24-33.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6004753
Downloads: Statistics Overview
Abstract
This study sought to assess the cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor (GPI) in thienopyridine-treated non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients undergoing early or urgent invasive management, from a United Kingdom National Health Service perspective.
| Faculties and Departments: | 03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs) |
|---|---|
| UniBasel Contributors: | Schwenkglenks, Matthias |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Elsevier |
| ISSN: | 1098-3015 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Identification Number: | |
| Last Modified: | 27 Feb 2014 15:45 |
| Deposited On: | 27 Feb 2014 15:45 |
Repository Staff Only: item control page